NASDAQ OMX

data Artisans to Host Third Annual Flink Forward Berlin with Featured Speakers from Alibaba, Google, ING and Netflix

2.8.2017 08:00 | NASDAQ OMX

Del

data Artisans / data Artisans to Host Third Annual Flink Forward Berlin with Featured Speakers from Alibaba, Google, ING and Netflix . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

World's Largest Apache Flink Event Unites 400 Community Members to Learn Best Practices for Apache Flink Deployments from Core Committers, Experts and Global Users

BERLIN, Aug. 02, 2017 (GLOBE NEWSWIRE) -- data Artisans, founded by the original creators of Apache Flink®, today announced the third annual Flink Forward Berlin, the premier conference for Apache Flink, including a sneak peek at the program agenda. The conference features more than 50 presentations and will take place September 11-13, 2017, at the KulturBrauerei in Prenzlauer Berg. For more information or to register to attend, please visit https://berlin.flink-forward.org/

Flink Forward Berlin will bring together 400 CTOs/CIOs, developers, DevOps engineers, system/data architects, data scientists, Apache Flink core committers and the open source stream processing community for hands-on training, technical sessions and networking opportunities. Participants will learn how global companies like Alibaba, Cisco, Google, IBM, ING, King and Netflix use Flink as the stream processing engine of choice for large-scale stateful applications, including real-time analytics, real-time search and content ranking, fraud/anomaly/threat detection.

Keynote Line Up Includes:

  • Xiaowei Jiang, senior director, Alibaba
  • Ferd Scheepers, chief information architect, ING
  • Kostas Tzoumas, PMC member of Apache Flink and CEO/co-founder, data Artisans
  • Stephan Ewen, PMC member of Apache Flink and CTO/co-founder, data Artisans

"Flink has quickly emerged as the leading enterprise-grade stream processing platform and is uniquely designed for large-scale, stateful applications," said Flink PMC member and data Artisans' CEO Kostas Tzoumas. "We've seen tremendous growth of the community over the past year as Flink applications have evolved beyond real-time analytics, now enabling businesses to respond to insights and to their customers in real-time. At Flink Forward Berlin, you'll hear about the business impact Flink is delivering across industries, how users are both building and operationalizing innovative real-time applications with Flink, and where the technology is headed."

At Flink Forward, participants will have the opportunity to hear from experts who have built scalable streaming infrastructure and enterprise-grade applications, view live demos and attend in-depth technical talks on the internals of stream processing technologies.

Sessions Include:

Flink Forward Berlin features one day of hands-on training as a lead in to the conference on September 11, followed by the two-day conference on September 12-13. For those new to Apache Flink, the Standard Training provides an in-depth introduction to stream processing with Flink. For experienced Flink users, the Advanced Training will focus on newer and more advanced understanding of the lower-level APIs and how to manage applications in production. For more information or to register to attend a training session and/or the conference, please visit https://berlin.flink-forward.org/

Join the Twitter discussion and follow #FlinkForward and @dataArtisans

Additional Resources

About Apache Flink 
Apache Flink is used by developers to analyze and process data streams of very high volume. By adopting Flink and a data streaming architecture, enterprises can act on insights from data in a matter of milliseconds, as well as cover existing historical data processing needs within a single platform. Flink is developed and supported by a vibrant and growing open source community with 10,000+ members and more than 325 contributors, of which data Artisans engineers are proud participants.

About data Artisans 
data Artisans was founded by the original creators of the Apache Flink project to enable enterprises to transition their data infrastructure to a streaming-based real-time architecture. Backed by Intel Capital, b-to-v Partners, and Tengelmann Ventures, data Artisans is based in Berlin, Germany with an office in San Francisco, Calif. For more information, visit http://data-artisans.com/.

"Apache", "Apache Flink", and their logos are registered trademarks or trademarks of The Apache Software Foundation in the U.S. and/or other countries.

Media Contacts:
Jessica Jaffe, Sift Communications, Jessica.Jaffe@siftpr.com 
Jill Reed, Sift Communications, Jill.Reed@siftpr.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: data Artisans via Globenewswire

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50Pressemelding

NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.  I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressemelding

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressemelding

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressemelding

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38Pressemelding

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical

CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00Pressemelding

CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom